213 related articles for article (PubMed ID: 14643939)
1. Reduced cortical gray matter density in human MDMA (Ecstasy) users: a voxel-based morphometry study.
Cowan RL; Lyoo IK; Sung SM; Ahn KH; Kim MJ; Hwang J; Haga E; Vimal RL; Lukas SE; Renshaw PF
Drug Alcohol Depend; 2003 Dec; 72(3):225-35. PubMed ID: 14643939
[TBL] [Abstract][Full Text] [Related]
2. Memory deficits associated with recreational use of "ecstasy" (MDMA).
Morgan MJ
Psychopharmacology (Berl); 1999 Jan; 141(1):30-6. PubMed ID: 9952062
[TBL] [Abstract][Full Text] [Related]
3. Medial prefrontal gray matter volume reductions in users of amphetamine-type stimulants revealed by combined tract-based spatial statistics and voxel-based morphometry.
Daumann J; Koester P; Becker B; Wagner D; Imperati D; Gouzoulis-Mayfrank E; Tittgemeyer M
Neuroimage; 2011 Jan; 54(2):794-801. PubMed ID: 20817105
[TBL] [Abstract][Full Text] [Related]
4. Brain serotonin synthesis in MDMA (ecstasy) polydrug users: an alpha-[(11) C]methyl-l-tryptophan study.
Booij L; Soucy JP; Young SN; Regoli M; Gravel P; Diksic M; Leyton M; Pihl RO; Benkelfat C
J Neurochem; 2014 Dec; 131(5):634-44. PubMed ID: 25041501
[TBL] [Abstract][Full Text] [Related]
5. A voxel-based PET investigation of the long-term effects of "Ecstasy" consumption on brain serotonin transporters.
Buchert R; Thomasius R; Wilke F; Petersen K; Nebeling B; Obrocki J; Schulze O; Schmidt U; Clausen M
Am J Psychiatry; 2004 Jul; 161(7):1181-9. PubMed ID: 15229049
[TBL] [Abstract][Full Text] [Related]
6. Evidence for chronically altered serotonin function in the cerebral cortex of female 3,4-methylenedioxymethamphetamine polydrug users.
Di Iorio CR; Watkins TJ; Dietrich MS; Cao A; Blackford JU; Rogers B; Ansari MS; Baldwin RM; Li R; Kessler RM; Salomon RM; Benningfield M; Cowan RL
Arch Gen Psychiatry; 2012 Apr; 69(4):399-409. PubMed ID: 22147810
[TBL] [Abstract][Full Text] [Related]
7. Human ecstasy (MDMA) polydrug users have altered brain activation during semantic processing.
Watkins TJ; Raj V; Lee J; Dietrich MS; Cao A; Blackford JU; Salomon RM; Park S; Benningfield MM; Di Iorio CR; Cowan RL
Psychopharmacology (Berl); 2013 May; 227(1):41-54. PubMed ID: 23241648
[TBL] [Abstract][Full Text] [Related]
8. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
de Sola Llopis S; Miguelez-Pan M; Peña-Casanova J; Poudevida S; Farré M; Pacifici R; Böhm P; Abanades S; Verdejo García A; Langohr K; Zuccaro P; de la Torre R
J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
[TBL] [Abstract][Full Text] [Related]
9. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
[TBL] [Abstract][Full Text] [Related]
10. MDMA use is associated with increased spatial BOLD fMRI visual cortex activation in human MDMA users.
Cowan RL; Haga E; deB Frederick B; Dietrich MS; Vimal RL; Lukas SE; Renshaw PF
Pharmacol Biochem Behav; 2006 Jun; 84(2):219-28. PubMed ID: 16782178
[TBL] [Abstract][Full Text] [Related]
11. Differences in prefrontal blood oxygenation during an acute multitasking stressor in ecstasy polydrug users.
Roberts CA; Wetherell MA; Fisk JE; Montgomery C
Psychol Med; 2015 Jan; 45(2):395-406. PubMed ID: 25066866
[TBL] [Abstract][Full Text] [Related]
12. Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems.
Parrott AC; Milani RM; Parmar R; Turner JD
Psychopharmacology (Berl); 2001 Dec; 159(1):77-82. PubMed ID: 11797073
[TBL] [Abstract][Full Text] [Related]
13. Human Ecstasy use is associated with increased cortical excitability: an fMRI study.
Bauernfeind AL; Dietrich MS; Blackford JU; Charboneau EJ; Lillevig JG; Cannistraci CJ; Woodward ND; Cao A; Watkins T; Di Iorio CR; Cascio C; Salomon RM; Cowan RL
Neuropsychopharmacology; 2011 May; 36(6):1127-41. PubMed ID: 21326196
[TBL] [Abstract][Full Text] [Related]
14. MDMA (ecstasy) use is associated with reduced BOLD signal change during semantic recognition in abstinent human polydrug users: a preliminary fMRI study.
Raj V; Liang HC; Woodward ND; Bauernfeind AL; Lee J; Dietrich MS; Park S; Cowan RL
J Psychopharmacol; 2010 Feb; 24(2):187-201. PubMed ID: 19304866
[TBL] [Abstract][Full Text] [Related]
15. N-acetylaspartate (NAA) correlates inversely with cannabis use in a frontal language processing region of neocortex in MDMA (Ecstasy) polydrug users: a 3 T magnetic resonance spectroscopy study.
Cowan RL; Joers JM; Dietrich MS
Pharmacol Biochem Behav; 2009 Mar; 92(1):105-10. PubMed ID: 19032963
[TBL] [Abstract][Full Text] [Related]
16. Attributions for psychobiological changes in ecstasy/MDMA and other polydrug users.
Soar K; Parrott A; Turner J
J Psychopharmacol; 2009 Sep; 23(7):745-58. PubMed ID: 18635698
[TBL] [Abstract][Full Text] [Related]
17. Discrete memory impairments in largely pure chronic users of MDMA.
Wunderli MD; Vonmoos M; Fürst M; Schädelin K; Kraemer T; Baumgartner MR; Seifritz E; Quednow BB
Eur Neuropsychopharmacol; 2017 Oct; 27(10):987-999. PubMed ID: 28866005
[TBL] [Abstract][Full Text] [Related]
18. MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes.
Reay JL; Hamilton C; Kennedy DO; Scholey AB
J Psychopharmacol; 2006 May; 20(3):385-8. PubMed ID: 16574712
[TBL] [Abstract][Full Text] [Related]
19. Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"): preliminary findings.
Reneman L; Lavalaye J; Schmand B; de Wolff FA; van den Brink W; den Heeten GJ; Booij J
Arch Gen Psychiatry; 2001 Oct; 58(10):901-6. PubMed ID: 11576026
[TBL] [Abstract][Full Text] [Related]
20. Reduced N-acetylaspartate levels in the frontal cortex of 3,4-methylenedioxymethamphetamine (Ecstasy) users: preliminary results.
Reneman L; Majoie CB; Flick H; den Heeten GJ
AJNR Am J Neuroradiol; 2002 Feb; 23(2):231-7. PubMed ID: 11847047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
